ab10231 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab10231 は 7 報の論文で使用されています。

  • Fu H  et al. NIPAAm-MMA nanoparticle-encapsulated visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis. Oncol Lett 15:4827-4836 (2018). PubMed: 29552122
  • Boutilier JK  et al. Gene Expression Networks in the Murine Pulmonary Myocardium Provide Insight into the Pathobiology of Atrial Fibrillation. G3 (Bethesda) 7:2999-3017 (2017). IHC-P ; Mouse . PubMed: 28720711
  • Kannappan R  et al. p53 Modulates the Fate of Cardiac Progenitor Cells Ex Vivo and in the Diabetic Heart In Vivo. EBioMedicine 16:224-237 (2017). PubMed: 28163043
  • Wile BM  et al. Molecular beacon-enabled purification of living cells by targeting cell type-specific mRNAs. Nat Protoc 9:2411-24 (2014). PubMed: 25232937
  • Moberly SP  et al. Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus. Basic Res Cardiol 108:365 (2013). PubMed: 23764734
  • Donaldson C  et al. Myosin cross-bridge dynamics in patients with hypertension and concentric left ventricular remodeling. Circ Heart Fail 5:803-11 (2012). WB . PubMed: 23014131
  • Ho M  et al. Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting. Protein Eng Des Sel 24:247-53 (2011). PubMed: 21051321

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録